Quarterly report pursuant to Section 13 or 15(d)

Income (Loss) Per Common Share - Schedule of Income (Loss) Per Common Share, Basic and Diluted (Details)

v3.23.1
Income (Loss) Per Common Share - Schedule of Income (Loss) Per Common Share, Basic and Diluted (Details) - USD ($)
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Net income (loss) available to stockholders $ (1,490,029) $ 89,409
Weighted average shares outstanding - basic 24,850,261 24,850,261
Effect of dilutive securities:    
Weighted average shares outstanding - Diluted 24,850,261 25,028,616
Net income (loss) per share - basic (in USD per share) $ (0.06) $ 0
Net income (loss) per share - diluted (in usd per share) $ (0.06) $ 0
Stock Options    
Effect of dilutive securities:    
Stock options 0 178,355
Anti-dilutive shares underlying stock options outstanding 1,744,351 928,271